NA
Novo Nordisk A/S
NVON.NE
OMX NORDIC EXCHANGE COPENHAGEN A/SHealth Care
Income Statement
Total Revenue$309.06B
Gross Profit$250.28B
Operating Income$0
EBITDA$0
EBIT$127.66B
Pre-tax Income$130.54B
Net Income$102.43B
Balance Sheet
Net Cash$264.64B
Cash Equivalent$26.96B
Total Debt$130.96B
Net Debt$-133.68B
Book Value$194.05K
Net Cash Per Share59620000.00
Book Value Per Share43.71
Key Ratios
Return on Equity (ROE)+52.79%
Return on Assets (ROA)+18.87%
Return on Invested Capital (ROI)+31.52%
Net Profit Margin+33.14%
Current Ratio0.80
Quick Ratio0.57
Long-Term Debt / Equity0.61